Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients and pharmaceutical intermediates, cooperative R & D, custom manufacturing, sales and service as well as import of pharmaceutical raw materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic pharmaceutical companies, including pharmaceutical applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provides factory quality management system certification consulting services.
Internationally, we has long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provides API registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our company's various chemical qualifications and certificates are complete, there are a variety of pharmaceutical intermediates and precursor chemicals, and most of the common dangerous goods business qualifications, and have complete import and export qualifications, the company's products are sold all over the world, and Acting for the import and export of various products such as hazardous chemicals.
The company is mainly engaged in wholesale, retail, biological products, pharmaceutical intermediates, first-class medical equipment, petroleum products, rubber products, plastic products, biological reagents, biochemical testing reagents and consumables, chemical reagents; pharmaceutical operations (operating with valid licenses) Import and export of goods and technology (except for projects prohibited by national laws and administrative regulations, and laws and administrative regulations stipulate that projects that restrict operations can only be operated after obtaining a permit). (Projects subject to approval according to law may be operated after approval by relevant departments)
China National Pharmaceutical Group Corporation (Sinopharm)
- As China's largest state-owned pharmaceutical conglomerate, Sinopharm has extensive capabilities in R&D and production of CNS drug ingredients, covering antidepressants, antipsychotics, and anesthetics. Its subsidiaries, such as Sinopharm Chemical Reagent Co., Ltd., specialize in raw material supply for central nervous system medications.
Zhejiang Hisun Pharmaceutical Co., Ltd.
- A leading Chinese pharmaceutical enterprise with a strong focus on CNS drug R&D. It produces key ingredients for antiepileptic drugs, sedatives, and analgesics, with products like carbamazepine and valproic acid raw materials exported globally.
Shandong Xinhua Pharmaceutical Co., Ltd.
- Renowned for its expertise in central nervous system drug production, Xinhua Pharmaceutical is a major supplier of ingredients for antipyretic analgesics and anesthetics, such as paracetamol and phenobarbital. Its products meet international standards (e.g., USP, EP).
Jiangsu Hengrui Medicine Co., Ltd.
- A pioneer in China's innovative drug development, Hengrui Medicine has a comprehensive layout in CNS drug ingredients, including raw materials for antidepressants (e.g., fluoxetine) and antineoplastic auxiliary drugs with CNS indications. It adheres to strict GMP standards for production.
CSPC Pharmaceutical Group Limited
- With a robust portfolio in CNS therapeutics, CSPC produces key ingredients for antianxiety drugs and central analgesics, such as diazepam and tramadol. The company integrates R&D, production, and sales, serving both domestic and international markets.
North China Pharmaceutical Group Corporation
- A state-owned pharmaceutical giant specializing in antibiotics and CNS drug ingredients. Its products include raw materials for sedatives and neuroprotective drugs, with a long history of compliance with international quality systems.
Fosun Pharma (Shanghai Fosun Pharmaceutical Group Co., Ltd.)
- Through global mergers and acquisitions, Fosun Pharma has expanded its CNS drug ingredient production, covering raw materials for antipsychotics and cognitive dysfunction drugs (e.g., donepezil). It operates production bases in China and overseas.
Zhejiang Huahai Pharmaceutical Co., Ltd.
- A leader in global generic drug development, Huahai Pharmaceutical focuses on CNS drug ingredients, such as antidepressant and antianxiety drug raw materials (e.g., paroxetine, venlafaxine). It has obtained multiple international regulatory approvals (e.g., FDA, EMA).
Lunan Pharmaceutical Group Co., Ltd.
- Specializing in traditional Chinese medicine and chemical drug integration, Lunan Pharmaceutical produces CNS drug ingredients for cerebrovascular protection and neuroregeneration, with a strong presence in domestic clinical markets.